Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
Phase 3
Active, not recruiting
- Conditions
- Moderately to Severely Active Ulcerative Colitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-11-25
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- Everstar Therapeutics Limited
- Target Recruit Count
- 341
- Registration Number
- NCT04176588
- Locations
- 🇨🇳
The First Affiliated Hospital of Fourth Military Medical University, PLA, Xi'an, Shanxi, China
News
No news found